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Abstract
Menopause is the permanent cessation of menstruation, and among the main symptoms 
reported have been night sweats, heat waves, increased body fat at the central level, 
dyslipidemia, hypertension, osteoporosis, insulin resistance, diabetes, mild cognitive 
impairment, depression, periodontitis, varicose veins, apnea, urinary genital discomfort, 
as well as dryness in the mouth and eye. The diagnosis, study, and care of menopausal or 
postmenopausal women have had great advances, such as recognizing the sub-inclusion 
of women and female animal models in basic and clinical studies and proposing in the 
same design of the study the analysis by sex. Subsequently, the need for specialized ethi-
cal training was identified, beginning in undergraduate, postgraduate, and clinical prac-
tice. To achieve this, several actions were carried out, such as the foundation of Women’s 
Health Institutes, the implementation of the Institutional and Private Committees of 
Ethic, and the development of validated instruments to evaluate signs and symptoms. 
Currently, there is no consensus that meets the ethical requirements for care and research 
in these patients. Efforts have been made practically by pathology, without consider-
ing together the social and psychobiological condition. What is intended in this docu-
ment is to present the ethical aspects related to the study and medical care of women in 
menopause.
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1. Introduction
The study of menopause and the medical care of women at this stage require a multidis-
ciplinary approach, given that the signs and symptoms observed are multiple. Therefore, 
obtaining reliable data depends on the researcher’s training, the experience and specialty of 
the medical treatment, the instruments used to obtain the information, and the degree of 
safety and security that the patient has both in the researcher and in the doctor.
The objective of clinical research is to obtain knowledge to incorporate it systematically in 
health policies. Specifically, research on women’s health began in 1990, when the Office of 
Research on Women’s Health (ORWH) promoted policies and funded research considering 
the influence of sex and gender on health. After, in 1991, the Women’s Health Initiative (WHI) 
announced, under which menopause was studied to understand the treatment of cardiovas-
cular diseases, cancer, and osteoporosis. In addition to promoting research in women’s health 
methodologically, technically, and more recently, ethical aspects have been analyzed, in order 
to protect the patient’s safety, in the social, psychological, and biological spheres. With respect 
to medical care, the influence of the sex of treating doctor or nurse has been studied, but no 
differences were observed; on the contrary, there was only predisposition to give preferential 
treatment to a family member, when in a hypothetical situation, the life was in high risk. 
Despite the fact that each gender is characterized by a type of ethical reasoning, is based on 
caring/protection for women and justice for men. Finally, for the study and medical attention 
of women, various surveys have been developed, with the aim to evaluate a specific sign or 
symptom. This fact highlights the importance of studying and attending multidisciplinary to 
women, given the complexity and diversity of the signs and symptoms.
The application of ethical norms for the investigation and medical attention of women 
requires that doctors and nurses from their professional formation have to approach to this 
concept. So also, the political authorities and administrators of economic funds must know 
the transcendence of ethics in their fields of action.
2. Social, psychological and biological characteristics of women in 
menopause
2.1. Hormonal profile, signs and symptoms
Menopause is the permanent cessation of menorrhagia, due to ovarian dysfunction, which 
marks the end of the reproductive stage in a woman’s life and is characterized by low levels 
of estradiol and high concentrations of follicle-stimulating hormone and luteinizing hormone, 
although other complex changes have also been reported in systems such as immunological 
and nervous among others [1]. Hormonal changes begin about 3 years before menopause and 
continue for a similar period after menopause; in addition, there are metabolic disorders that 
induce characteristic signs and symptoms such as vasomotor and psychological, whose dura-
tion ranges from 3 months to 5 years after menopause [2]. Central obesity, dyslipidemia, sleep 
disorders, and high blood pressure, among others, are also identified [3–5].
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Several symptoms have already been described widely; so here, only some will be described 
that require special mention given the complexity to diagnose or study them, or those of the 
major importance, or they have recent advances.
Sexual dysfunction: In general, menopause is usually perceived as a stage of decline, because 
signs and symptoms are accentuated with aging. One of the symptoms that usually cause 
embarrassment in female patient is the sexual dysfunction, which has a final result, the 
reduction of sexual desire [6]. The events that lead to this can be pathophysiological such as 
vulvar and vaginal atrophy and lubrication reduction or psychological, due to women who 
present low self-esteem. Sexual function in this stage is influenced by several factors, such 
as previous sexual activity, co-morbidities, cultural environment, mental illness, and ethnic 
origin; for example, the prevalence of sexual desire reduction has been described in 47, 54, 
42, and 24% in English, Italian, French, and German menopausal women, respectively. It 
has also been pointed out that black and Latina women had greater sexual desire than white 
and Asian women at this stage. Although even women from the same country, but of dif-
ferent ethnic groups, tend to have a different prevalence of sexual dysfunction, as shown 
in a study carried out in ethnic groups from Iran, that study showed that the prevalence of 
sexual dysfunction was 75.3 in Arabs, 86.1 in Lors, and 83.2% in Persians [7]. Undoubtedly, 
the evaluation of the sexual function requires an ethical management by the treating medical 
personnel, since it must auscultate and interrogate the patient, without the woman feeling 
uncomfortable.
Osteoporosis: It is another important health problem in women postmenopausal, which 
usually occurs in the late phase but goes unnoticed because it is not painful or by patient’s 
ignorance. This pathology results from the decrease in estrogen production, reduced calcium 
resorption, increased urinary excretion, reduced vitamin D synthesis, as well as less forma-
tion of its active metabolites, decrease in the number of vitamin D receptors. The analysis 
of the quality of life of women with osteopenia or osteoporosis is important, as it can guide 
pharmacological and non-pharmacological strategies [8].
Obstructive sleep apnea: It is neither a symptom usually asked by doctors nor does the 
patient report having more episodes in this stage. However, clinical research found a higher 
prevalence after menopause, and even more, it has been proposed that it predisposes to 
enuresis, coronary risk, and cardiovascular disease. Enuresis, occurs during the apnea as a 
result of a negative pressure against the glottis, which causes cardiac distension and greater 
release of the atrial natriuretic peptide, which finally results in an increased urinary volume 
and, consequently, enuresis [9]. Then, the knowledge factors to obstructive sleep apnea 
can also control the enuresis, improve the quality of sleep, and reduce cardiac risk, the 
mood, and, in general, the well-being. Common risk factors for obstructive sleep apnea and 
enuresis have been reported, such as obesity, snoring, restless sleep, sleep fragmentation, 
daytime somnolence, and hypertension; this has not been found in postmenopausal women 
(Figure 1) [10].
2.2. Influential factors in the symptomatology
As already mentioned, there are several condition factors of the presence and intensity of a cer-
tain symptom of menopause and therefore the type of treatment that they will receive to control 
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them. Several studies indicate that among these factors are the psychological, cultural, and fam-
ily factors, additionally to events that usually occur around the age of menopause [11].
Personality is part of the human being and is defined as the series of features or characteristics 
that induce the behavior of a person, in turn, allowing us to intuit the way of acting in a given 
situation. The personality is defined by traits such as neurosis, extroversion, openness to new 
experiences, kindness, and scrupulousness. The identification of this traits could guide the 
pharmacological and non-pharmacological strategies to reduce the anxiety and to improve 
the self-esteem and, with that, the self-care of the patient [12]. Of the different personality 
traits, the one that has been most related to the presence of vasomotor symptoms is the neuro-
sis, since it predisposes anxiety, stress, hostility, impulsivity, low self-esteem, and depression, 
which in turn conditions feelings such as sadness, anger, and guilt. Although results of clini-
cal studies in postmenopausal women are contradictory, for example, it has been reported 
that neurosis and anxiety are associated with physical symptoms; in contrast, in others, no 
correlation has been found with the number of hot flushes [13].
Another aspect that is not usually considered in the consultation is the possibility that the 
woman suffers some type of mistreatment (sexual, economical, or physical) which has been 
proven to diminish physical capacity functioning (Figure 2) [14].
Figure 1. Interrelationship between signs and symptoms with diseases observed during menopause and its stages.
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2.3. Advantages of menopause
Many clinical research and medical care to postmenopausal patients has been focuses 
to treat diseases, uncomfortable symptoms, or family problems; without consider the 
advantages that menopause has; in example, there is no possibility of becoming preg-
nant, so, the women can enjoy their sexuality. Also, women can do activities that satisfy 
them [7].
The menopause is an opportunity to empower women. To achieve the above, it is necessary 
that the woman is better informed of physical and psychological changes she will undergo, 
of family and medical needs, as well as of the strategies she can carry out for her self-care 
[15]. Because approximately half of the world’s population is woman, and the life expectancy 
is greater than that of man, it can be intuited that women spend two thirds of their lives in 
postmenopausal, so their functional status must be preserved, since it will impact on the fam-
ily, society, and itself. It is important to recognize those factors that hinder empowerment, 
for example, co-morbidities present before menopause, marital status, family network, and 
health centers that can be accessed.
Currently, campaigns have been implemented to prevent and treat osteoporosis: follow 
a healthy diet and promote moderate physical activity, stress management, interpersonal 
relationships, and group education, which will improve the quality of life. If menopause is 
accepted with the inherent changes, it will bring the woman to face this stage better; in contrast, 
Figure 2. Factors and events that influence the presentation of symptoms during menopause.
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it has been reported that women who do not accept this stage have more severe symptoms. In 
targeted studies, women in menopause have expressed that they need to be informed of this 
stage through different means [16].
3. Bioethics in the clinical care of women in menopause/
postmenopause
3.1. Advances in bioethics
Defining “ethics” or “ethical thinking” is complex and has basically focused on two approaches; 
one is based on care and prior experience, and the other is on justice, as outlined by Gilligan and 
Kohlberg, respectively. The first one is manifested by women, while the second one, by men 
which, of course, should not be generalized, but its foundation is derived from biological traits 
and the activity of each sex. For example, Gilligan proposes that women understand ethics, 
based on their role in the family and society, that is, in caring for and supporting family mem-
bers equally and providing them with care, while men focus on ethics, according to the rights 
and obligations of people; this means that people should receive the just [17]. Both theories 
raise divergences and difficulties to define ethics and all the components that integrate it, even 
if there are different types of ethics (professional, economic, and government, among others).
Conduct clinical studies in doctors and nurses with a gender perspective, who provide medi-
cal attention is very important, given that they can influence the ethical treatment received by 
menopausal patients, who are in the stage of emotional and physiological  susceptibility [18].
A study with doctors and nurses of both sexes was carried, to evaluate their impartial reason-
ing; starting from the assumption that women doctors and nurses have a partial thought (care 
orientation) and impartial men (focused on justice). The dilemmas presented situations of dif-
ferent severities and urgencies, whether the life of a relative was in danger or not. It was found 
that the response was partial, if the life of a relative was in danger, both in health professionals 
and in those who were not, while if it was a less serious situation that did not compromise life, 
the response was impartial, in both cases. In summary, what conditioned the response was 
the seriousness of the situation.
This ethical requirement for doctors has been diffused in several centuries and is raised in 
the “Hippocratic Oath,” which connects the responsibility of the doctor, with the result of 
his intervention. Subsequently, the principles of “first do no harm” and “beneficence and no 
maleficence” were included. Since then, several researchers have contributed to define “ethics 
and bioethics” as well as their scope. In 1979, Beauchamp and Childress concretized concepts 
and focused on “biomedical ethics.” On the other hand, in the Belmont report, “principlism” 
was defined, which focuses on respecting people with justice. In 1847, the American Medical 
Association began to define the doctors’ behavior [19].
In 1980, the teaching of bioethics was implemented in the undergraduate program and later 
in the specialties. Thus, the first thing that was emphasized was the basic concept of bioethics. 
Surgery residents surveyed indicated that they felt more confident to face ethical problems, 
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after a training program. A study in pediatric residents indicated that they needed ethical 
training, especially to make the decision to give or take life support [20].
Several studies indicate that (1) medical women trained in ethics perceive more benefits than 
men and (2) student women focused more on psychosocial aspects and men were based on 
the rights of the patients. This shows that women are more based on abstract and personal 
principles, while men focused on responsibility, authority, and control. It is necessary to make 
a systematic analysis by the specialty and educational level, considering areas of special inter-
est such as the role of bioethics and the conceptualization of justice, obtaining the informed 
consent of the patient or from a legal representative, facing the rejection of the signature of the 
said document, as well as obtaining it from people who speak different languages and care for 
special people or with a certain degree of vulnerability. Recognizing the training needs of the 
different specialties and taking into account the evolution of bioethics, better-oriented ethics 
programs can be designed.
A survey at the School of Medicine of the University of New Mexico to better understand these 
problems was conducted. The hypotheses were that (1) medical students and residents would 
support the need for more curricular attention to the principles of bioethics, the issues of informed 
consent, and the special needs of the population; (2) women would more strongly support these 
curricular needs; (3) residents of psychiatry would more strongly support curricular needs than 
other residents; and (4) there would be a greater perceived need in these curricular domains of 
ethics among apprentices who were in more advanced stages of training (Table 1) [21].
3.2. Diseases and ethical considerations
Among the diseases that affect menopausal women, there are some that are deserved to be 
explained with ethical focus, for example, osteoporosis, periodontal disease, and vaginal 
symptoms.
Osteoporosis is a disease that occurs in women in late postmenopausal; in fact, according 
to the National Osteoporosis Foundation, every second, a woman suffers a fracture due to 
osteoporosis, and even the risk for this disease is higher than for other gynecological cancers. 
Therefore, studies have been developed that measure the quality of life of these patients, who 
are determined by their degree of functionality. This has been confirmed in women with 
osteopenia and osteoporosis; since they have limited physical activity, they have altered the 
physical position, suffering, and pain, with mental and emotional alterations [22].
There are many approaches that have been given for the prevention, treatment, and study of 
osteoporosis. Primary prevention means promoting habits that encourage the formation of 
good quality bones; also, at this stage, the primary detection is carried out, and the modifiable 
risk factors are identified, or they can be reduced or eliminated. Secondary prevention implies 
the opportune diagnosis and its pharmacological and non-pharmacological treatment, before 
a fracture occurs. Tertiary prevention is directed to limit the damage by osteoporosis.
Vaginal symptoms: Like the vasomotor symptoms, the vaginal symptoms are frequent. 
The clinical evaluation of these manifestations is not easy, and validated questionnaires are 
required that can be understood and answered by the same patient, as well as being able to be 
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applied in populations of different ethnic origins. For which, an instrument of 100 questions 
was developed, with a set of 100 structured items, which used ordered 5-point response options 
to assess the degree to which vaginal symptoms interfered with specific aspects of women’s 
daily activities, sexual function, emotional well-being, self-concept and body image, or inter-
personal relationships. The aspects evaluated included sexual function, emotional well-being, 
the concept of self-perception, and personal interrelationships. According this questionnaire, 
the main symptoms were dryness, dyspareunia, and itching, and there was a lower prevalence 
Organization Aim
Women’s Health Initiative (WHI) Was founded by the US National Institutes of Health (NIH) in 1991. This 
Initiative consisted of clinical trials and observational studies in order to conduct 
the main health issues causing morbidity and mortality in postmenopausal 
women
Women’s Health Initiative Clinical 
Trial (WHICT)
This study was initiated in 1992 and concluded in 2007, in which the patient was 
included in a trial clinic or an observational study. Both focused to study the 
prevention of cancer, cardiovascular diseases, or osteoporosis
Institute of Nutrition of Central 
America and Panama (INCAP)
Was constituted in 1949, under three principles:
• To identify the nutritional problems
• To find practical solutions
• To apply the solutions in the countries of the region (Belice, Costa Rica, 
El Salvador, Guatemala, Honduras, Nicaragua, Panamá y República 
Dominicana)
National Research Ethics Service 
(NRES)
NRES is one of the functions of the Health Research Authority and is responsible 
for reviewing and supporting ethical research in the National Health Service “to 
guarantee the protection of the human rights, safety, dignity, and well-being of 
the participants in the research”
Canadian Institutes of Health 
Research
Is the main federal agency for health research in Canada. It is constituted by 13 
institutes, among which is the “Gender and Health”
Office for Human Research 
Protections (OHRP)
The Office for Human Research Protections (OHRP) is responsible for protecting 
the rights and welfare of individuals who participate in research projects 
conducted under the authorization of the US Department of Health and Human 
Services (HHS)
Council for International 
Organizations of Medical Sciences 
(CIOMS)
The Council for International Organizations of Medical Sciences was established 
in 1949 by the WHO and UNESCO, who are integrated international researchers, 
academies of science, and medical research councils. CIOMS promotes the 
public health, applying guides of health research, ethics, new products, and its 
security
Canadian Medical Association 
(CMA)
CMA was founded in 1867, its members are volunteers, and doctors promote 
patient access to high-quality health services
World Medical Association (WMA) WMA was founded in 1947 and is formed by several millions of physicians and 
medical associations, promoting the medical care, ethics, and health education
European Society for Clinical and 
Economic Aspects of Osteoporosis 
and Osteoarthritis (ESCEO)
ESCEO was founded in 2005; it is a not-for-profit organization that meets clinical 
scientists who study bone, joint, and muscle disorders, as well as pharmaceutical 
industry
Table 1. Organizations involved in women’s health.
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Name Symptoms evaluated Score
Female Sexual Function 
Index (FSFI) [26]
Dimensions of sexual function in women Range: 1.2–36 points
≤ 26.55 is classified as FSD
Physical Function Scale (PFS) 
[27]
Physical function, social function, role 
limitations: physical problems, emotional 
problems, mental health, vitality, pain, and 
perception of general health
Range: 0–100 points
High scores reflect better health 
status
Center for Epidemiologic 
Studies Depression (CESD) 
Scale [28]
Depression, such as restless sleep, poor 
appetite, and feeling lonely
Range: 0–60 points
High scores indicate greater 
depressive symptoms
Epworth Sleepiness Scale [29] Daytime sleepiness Scores: 0–5 lower normal, 6–10 
higher normal, 11–12 mild excessive, 
13–15 moderate excessive, 16–24 
severe excessive
Pittsburgh Sleep Quality 
Index [30]
Subjective sleep quality, sleep latency, sleep 
duration, habitual sleep efficiency, sleep 
disturbances, use of sleeping medication, and 
daytime dysfunction
Range: 0–21 points
< 5 have good sleep quality
STOP-Bang Questionnaire 
[31]
Consists of yes/no responses:
“Do you snore loudly?”
“Do you often feel tired, fatigued, or sleepy 
during daytime?”
“Has anyone observed you stop breathing 
during your sleep?”
“Do you have or are you being treated for high 
blood pressure?”
Range: 0–8 points
≥3 suggest obstructive sleep apnea
Charlson Comorbidity Index 
[32]
Categorize co-morbidities: each co-morbidity 
category has an associated weight (from 1 to 6)
0 = no co-morbidity
3 = severe co-morbidities
Dietary Inflammatory Index 
(DII) [33]
Related to the type of diet with the increase or 
decrease of inflammatory mediators IL − 1beta, 
IL-4, IL-6, IL-10, TNF-alfa, and PCR
-1 = pro-inflammatory foods
0 = they do not produce changes in 
inflammatory markers
+1 = anti-inflammatory foods
Day-to-Day Impact of 
Vaginal Aging (DIVA) [34]
Assessing the impact of vaginal dryness, 
soreness, itching, irritation, and pain on 
functioning and well-being
Range: 0–4 points
Higher score indicates major 
symptoms
Hospital Anxiety and 
Depression Scale (HADS) 
[35]
Depression and anxiety in hospitalized 
nonpsychiatric patients
Range: 0–42 points
0–7 normal
8–10 doubtful
>11 clinic problem
Quality of Life Questionnaire 
of the European Foundation 
for Osteoporosis 
(QUALEFFO) [36]
Pain, physical function, social function, general 
perception of health, and mental function
Range: 1–5 points
The highest score refers to the 
quality of worse life
Health Behavior Inventory 
(HBI) [37]
Dietary self-management, preventive 
measures, healthy practices, and positive 
mental attitude
Range: 24–120 points
The higher score indicates health 
behaviors
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of irritation and pain. The questionnaire was useful to evaluate the vaginal function, since it 
also evaluates feeling good, sexual function, and self-perception of the image [23].
Periodontal disease: A study carried out in postmenopausal women reported that 97% thought 
they had healthy gums, but when were evaluated, it was identified that 62% had at least one 
affected site, with the risk of losing a dental organ. In addition, women were unaware of the 
effects of periodontitis. Although women reported that they visited their dentist semiannu-
ally, in several teeth, the biofilm was observed, but in several teeth, biofilm was observed, 
which indicated a poor periodontal state; what makes us suppose is that they considered that 
they had healthy gums, because they did not present abscesses, a symptom that seems to be 
the best known, not considering important events such as the loss of periodontium and depth 
of probing. Periodontal disease is not well known among women, although they know the 
risk factors for developing caries, such as the infrequency of brushing, poor dental technique, 
and sugary foods. The study showed that most of the patients neither had knowledge about 
the risk factors nor of all the signs and symptoms, but once it was explained to them, they 
showed greater interest in self-care and assisted a periodic review by the specialist [24].
Name Symptoms evaluated Score
Health Promoting Lifestyle 
Profile II (HPLP II) [38]
Health responsibility (HR), spiritual growth 
(SG), physical activity (PA), interpersonal 
relations (IR), nutrition (N), and stress 
management (SM)
Score: ≥2.50 is considered to be a 
positive response
Neuroticism-Extroversion-
Openness Five-Factor 
Inventory (NEO-FFI) [12]
The NEO-FFI is integrated by 60 items, which 
measures the five main domains (neuroticism, 
extraversion, openness to experience, 
agreeableness, conscientiousness)
Higher scores in neuroticism is 
related to severe menopausal 
symptoms
Menopause-Specific Quality 
of Life Questionnaire 
(MENQOL) [39]
MENQOL evaluates the quality of life after 
menopause through: vasomotor, physical, 
psychosocial, sexual, and global quality of life 
question
Range: 0–6 points
(0 none, 6 severe)
Kupperman Index [40] Hot flashes, paresthesia, insomnia, vertigo, 
nervousness, melancholia, weakness, arthralgia 
or myalgia, headache, palpitations, and 
formication
Scores:
15–20 = mild
20–35 = moderate
>35 = severe
Psychological General Well-
Being Index [41]
Anxiety, depressed mood, positive well-being, 
self-control, general health, and vitality
Range: 0–100 points
A high score is indicative of high 
levels of psychological well-being
Hot Flash Related Daily 
Interference Scale (HFRDIS) 
[42]
Work, social activities, leisure activities, sleep, 
mood, concentration, relations with others, 
sexuality, and enjoyment of life
Range: 0–100 points
High score indicates interference
Menopause Rating Scale 
(MRS) [43]
Hot flushes, heart discomfort, sleep problems, 
depressive mood, irritability, anxiety, physical 
and mental exhaustion, sexual problems, 
bladder problems, dryness of vagina, joint, and 
muscular discomfort
Range: 9–21 points
Higher score is related to more 
postmenopausal symptoms
Table 2. Questionnaires, survey and index used to evaluate women’s health.
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Physical activity: The index of healthy behavior considers four areas: healthy eating habits, 
preventive actions, positive mental attitude, and recreational activities. Using this instrument, 
a comparison was made between young and old women, in which it was found that the elder-
lies (between 56 and 69 years) have a high level of healthy behavior, although in a particular 
way the alimentary habits were similar and women with the higher educational level and 
who are divorced had more healthy habits. Women with some pathology had higher scores; 
this is expected, since they know that they have an illness and they understand that they 
must have more care and carry out actions that benefit their health and control the disease. 
On the other hand, women without pathologies had less healthy habits, a situation derived 
from their perception of their health, since they considered their health status as good. This 
type of instrument is of fundamental application in postmenopausal women, since it has been 
proven that a healthy state will condition symptoms of less intensity or frequency [25]. There 
are several survey questionnaires or scales to evaluate women’s health but, however, is not 
usually used all at the same time (Table 2).
4. Clinical research
Since its inception in 1906, the Food and Drug Administration (FDA) has been committed to 
the health of women and stablished the Office of Women’s Health (FDA OWH) in 1994. The 
US Food and Drug Administration Guide developed a Guide for the Study and Evaluation 
of Gender Differences, which made it possible to include women in phase 1, 2, and 3 studies. 
Later, between 2002 and 2004, trials on hormone therapy were designed to test the effects of 
estradiol and combined estrogen/progesterone therapy on the prevention of cardiovascular 
diseases, fractures, and breast and colorectal cancer. The studies found that estradiol did not 
protect against cardiovascular disease and that the risks outweighed the benefits. In the year 
2010, it was recognized that it was necessary to carry out research with female animals with a 
focus on the study of common diseases. Finally, the inadequate number of women included 
in clinical trials is noteworthy [44].
In that same year, the NIH Office of Research on Women’s Health proposed a strategic plan-
ning process with scientists, public policy experts, women’s health advocates, healthcare pro-
viders, elected officials, and the public to generate priorities research. In 2014, federal agencies 
collaborated with women’s health research. The NIH Office of Research on Women’s Health 
and the Office of Women’s Health of the FDA plan to collaborate on a national campaign to 
promote the importance of participation in clinical trials focusing on women; due to evidence 
of the effect of estrogen in the secondary prevention of coronary disease, published in The 
Journal of the American Medical Association in 1973, was conducted only with men, enrolling 
8341 men and not women [44].
Three main reasons seem to explain the exclusion of women: (1) experimental exposition to 
risk during fertile years (2) erroneous perceptions that consider that women are less affected 
by certain disorders or health problems or that women respond to the same treatment as 
men; and (3) it is perceived that women provide complexity, increased cost, and the need for 
greater analytical capacity.
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However, the Institute of Medicine concluded “being male or female is an important basic 
human variable that must be considered when designing and analyzing studies in all areas 
and at all levels of biomedicine and health-related research.” Until sex and gender differences 
are routinely investigated, there will be many opportunities to gain a better understanding of 
the pathogenesis of disease and human health.
Currently, the review of clinic protocols by the Research Ethics Committees (REC) is the key 
to the regulation of clinical research. The RECs have to comply with several requirements, 
such as (1) the minimum members is five; (2) membership must be diverse (by race, gender, 
cultural background, sensitivity to the problems of the community), with at least one scien-
tist and one nonscientist [45]; (3) there are no rules about how fast decisions should be made 
or how many times you could apply; (4) the consequences of REC’s work for investigators 
or research funders, in terms of time or resources, were not a consideration of REC; (5) the 
scientific quality of a project is considered an ethical prerequisite; (6) the legality (to ensure 
that laws and other regulations are followed and the protection of institutes and responsible 
researchers); (7) the choice of researchers is determined by the professional location of the 
principal investigator, which a REC within the health institute could be chosen. The research-
ers did not choose the REC; (8) the REC had “responsibility of state public officials”; (9) 
transparency in the selection process to accept protocols; (10) compulsory education of REC 
members about ethical topics; (11) the variability in the work and decisions of REC had been 
recognized as a problem, but not solved; and (12) quality assurance investigation complicates 
the topic, but some defended the exemption from quality assurance studies of the ethical 
approval requirement.
5. Challenges in bioethics research and medical care
Currently, it is recognized that health is fundamental to development of a society. Most 
studies describe the costs of poor health in women, particularly the costs of poor maternal 
health.
There are a lot of challenges that REC and national or international organizations have to 
solve, for example:
1. Girls from the United States exhibited physical signs of puberty by age 7.
2. Pollutants of land and livestock can impact on man’s reproductive abilities.
3. Good health among women is important for child development and the production of 
future human capital.
4. The mass and nonprofessional media can be the main source of knowledge about the 
symptoms and coping methods in postmenopausal women.
5. Determining the association of quality of life of the postmenopausal women with that of 
their spouses.
6. Promoting the health and health behavior must be a priority [11, 25, 46].
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6. Conclusions
Menopause is a very important stage in a woman’s life, and the attention provided at this 
stage, whether for research or medical attention, must be carried out by personnel trained in 
ethics, because the woman is in the stage of major susceptibility; also, several symptoms can 
be confusing. Moreover, in medical consultation or the clinical studies, do not usually apply 
all the questionnaires, indexes, or scales, either due to lack of time or to focus on the main 
symptom, without considering that the symptom that was the reason for consultation may 
be the result of not treating other minor symptoms. The research clinic based on ethical prin-
ciples will contribute to obtain specific and reliable results on women’s health.
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